A detailed description of the thermal relaxation processes in MEH−PPV is reported. Bulk methods such as DMTA were employed in conjunction with other techniques that probe molecular motions, such as fluorescence spectroscopy, thermal stimulated current, and 13C NMR. From the two main transitions observed (glass transition process at 340 K and β-relaxation between 200 and 220 K), it was demonstrated that the first is strongly correlated with the dissociation of a fluorescent emissive interchain complex and that the second relaxation involves movements of the lateral substituents of the polymer backbone and, more specifically, their CH2 groups. NMR dipolar chemical shift correlation experiments pointed an increasing gain in mobility through the side chain, the lateral carbons close to the aromatic ring being more rigid than those located more distant from the main polymer chain. A kinetic model involving the dissociation of interchains to re-form intrachain excitons was proposed to explain the profiles of the photoluminescence spectra at higher temperatures.

Since many potential drugs are poorly water soluble, there is a high demand for solubilization agents. Here, we describe the synthesis of dendritic core-shell-type architectures based on hyperbranched polyglycerol for the solubilization of hydrophobic drugs. Amphiphilic macromolecules containing hydrophobic biphenyl groups in the core were synthesized in an efficient three- or four-step procedure by employing Suzuki-coupling reactions. These species were then used to solubilize the commercial drug nimodipine, a calcium antagonist used for the treatment of heart diseases and neurological deficits. Pyrene was also used as a hydrophobic model compound. It turned out that the transport properties of the dendritic polyglycerol derivatives, which are based on hydrophobic host-guest interactions, depend strongly on the degree and type of core functionalization. In the case of the multifunctional nimodipine, additional specific polymer-drug interactions could be tailored by this flexible core design, as detected by UV spectroscopy. The enhancement of solubilization increased 300-fold for nimodipine and 6000-fold for pyrene at a polymer concentration of 10 wt%. The sizes of the polymer-drug complexes were determined by both dynamic light scattering (DLS) experiments and transmission electron microscopy (TEM), and extremely well-defined aggregates with diameters of approximately 10 nm in the presence of a drug were observed. These findings together with a low critical aggregate concentration of 4x10(-6) mol L-1 indicate the controlled self-assembly of the presented amphiphilic dendritic core-shell-type architectures rather than a unimolecular transport behavior.

No abstract

No abstract

No abstract